| CTNT 0.1608 -5.80% | ZSPC 0.0871 21.48% | ONFO 1.5 124.89% | MYSE 3.3 129.17% | NVDA 198.35 -0.26% | BITO 10.35 0.49% | TZA 5.43 -0.46% | TSLL 13.07 -1.73% | INTC 68.5 5.48% | CAPS 0.5345 -9.25% | HUBC 0.1833 -29.50% | DVLT 0.8375 19.63% | SOXS 20.28 -3.13% | TQQQ 56.43 1.40% | QBTS 21.505 3.34% | AGAE 0.5219 10.57% | HIMS 26.99 11.12% | IONQ 44.68 3.31% | DGNX 0.5556 -0.79% | GRAB 4.02 2.55% | SNAP 6.02 -0.33% | SOFI 19.03 1.28% | SMR 11.41 -2.56% | TSLA 388.9 -0.78% | ITP 0.2 -3.57% | BMNG 1.53 0.66% | SOXL 88.37 2.80% | AMD 278.26 7.80% | RGTI 19.45 1.78% | OPEN 5.27 9.34% | MDCX 0.3003 -0.60% | PLUG 2.86 -2.39% | MARA 11.55 10.32% | NVD 5.81 0.69% | AAL 12.27 0.82% | SQQQ 58.61 -1.40% | IMMP 0.5796 6.54% | HOOD 86.85 -0.54% | ONDS 10.2 1.69% | NVTS 12.37 20.57% | RMSG 2.55 42.46% | BYND 0.782 4.11% | NOK 10.29 3.00% | NFLX 107.79 0.07% | ORCL 178.46 5.09% | SPY 701.66 0.25% | SOUN 7.7 -1.91% | AAPL 263.4 -1.14% | PBM 5.87 103.82% | PLTR 142.76 0.43%

Bath & Body Works Beats Q4 Estimates but Forecasts Sales Decline in 2026

Bath & Body Works, Inc. (NYSE: BBWI) reported fourth-quarter results that topped analyst expectations, although the company projected weaker sales for fiscal 2026 as it continues executing a transformation strategy. Shares rose more than 4% intra-day Wednesday following the report.

The retailer posted adjusted earnings per share of $2.05 for the quarter ended January 31, exceeding the $1.75 consensus estimate by $0.30. Revenue reached $2.7 billion, surpassing expectations of $2.6 billion but declining 2% from $2.8 billion in the prior-year quarter.

The company said the quarter benefited from faster product innovation and the earlier-than-planned launch of its products on Amazon.

For fiscal 2026, Bath & Body Works expects adjusted earnings per share between $2.40 and $2.65. The midpoint of $2.53 is below the analyst consensus estimate of $2.59. Net sales are projected to decline between 4.5% and 2.5% compared with fiscal 2025 revenue of $7.3 billion.

For the first quarter, the company forecasts adjusted earnings per share between $0.24 and $0.30, compared with $0.49 in the first quarter of 2025. Net sales for the period are expected to decline between 6% and 4%.

For fiscal 2025, Bath & Body Works reported adjusted earnings per share of $3.21, compared with $3.29 in 2024. Annual net sales totaled $7.3 billion, down slightly by 0.2% year over year.

Published on: March 4, 2026